Patent Assignment
Reel/Frame 071501/0674
Change of Name
Recorded: 2025-06-10
Pages: 4
Assignor
MYMD PHARMACEUTICALS, INC.
Executed: 2024-07-22
Assignee
TNF PHARMACEUTICALS, INC.
855 N. WOLFE STREET, SUITE 623, BALTIMORE, MARYLAND, 21205
Covered Property
(1)
Methods of Regulating Oxidoreductase Activity for Treatment of Chronic Obstructive Pulmonary Disease (Copd).
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 11, 2021
From: WILLIAMS, JONNIE R.
To: MYMD PHARMACEUTICALS, INC.
Reel/Frame 058088/0984 →
Change of Name
Nov 15, 2021
From: MYMD PHARMACEUTICALS, INC.
To: MYMD PHARMACEUTICALS (FLORIDA), INC.
Reel/Frame 058110/0049 →
Merger
Apr 22, 2022
From: MYMD PHARMACEUTICALS (FLORIDA), INC.
To: MYMD PHARMACEUTICALS, INC.
Reel/Frame 059680/0941 →